Skip to content

Clinical trials

Observational Diabetes Mellitus, Type 2 trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Observational Country / region: Japan Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20041
20061
20091
20103
20116
20124
20133
20148
20152
20161
20173
20182
20192
20202
20212
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Unknown status4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S17
Boehringer Ingelheim7
AstraZeneca6
Takeda6
Nagaoka Red Cross Hospital4
Astellas Pharma Inc2
Bayer2
Eli Lilly and Company2
Dokkyo Medical University1
Kanagawa Physicians Association1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 251
Diabetes Mellitus17
Diabetes Mellitus, Type 18
Insulin Resistance3
Renal Insufficiency, Chronic3
Dyslipidemias2
Hypertension2
Atherosclerosis1
Body Weight1
Diabetic Nephropathies1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.